MDRX Veradigm Inc.

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments: The Core Clinical and Financial Solutions; and The Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for patient engagement, and integrated clinical and financial management solutions, which primarily include EHR-related software; and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Data, Analytics and Care Coordination segment offers practice reimbursement, and payer and life sciences solutions, which are primarily targeted at physician practices, payers, life sciences companies, and other healthcare stakeholders. Its solutions enable clients to transition, analyze, and coordinate care and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Recent Analyst Ratings for Veradigm Inc.

Date	Price Target	Rating	Analyst
3/19/2024	$15.00 → $10.00	Buy → Hold	Deutsche Bank
1/3/2024	$11.00	Equal Weight	Barclays
7/6/2023		Buy → Hold	Argus
4/12/2023	$13.00	Equal-Weight	Stephens
2/1/2023	$17.00 → $18.50	Overweight → Neutral	Piper Sandler
12/7/2022	$26.00	Hold → Buy	Argus
11/9/2022	$22.00 → $23.00	Neutral → Buy	Goldman
11/4/2022	$17.00	Overweight	Piper Sandler
9/16/2022		Sector Weight	KeyBanc Capital Markets
7/12/2022	$21.00	Neutral	Goldman

See more ratings

Veradigm Inc.

Peers

Recent Analyst Ratings for Veradigm Inc.

Veradigm Inc. SEC Filings

SEC Form 8-K filed by Veradigm Inc.

SEC Form NT 10-Q filed by Veradigm Inc.

SEC Form SCHEDULE 13G filed by Veradigm Inc.

SEC Form 8-K filed by Veradigm Inc.

SEC Form 8-K filed by Veradigm Inc.

Amendment: SEC Form 8-K/A filed by Veradigm Inc.

Veradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

Amendment: SEC Form 8-K/A filed by Veradigm Inc.

Veradigm Inc. filed SEC Form 8-K: Leadership Update

Amendment: SEC Form 8-A12G/A filed by Veradigm Inc.

Veradigm Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SVP & Chief HR Officer Hammond Lisa was granted 58,140 shares, increasing direct ownership by 50% to 174,175 units (SEC Form 4)

SVP General Counsel Vakharia Tejal was granted 69,768 shares, increasing direct ownership by 22% to 387,476 units (SEC Form 4)

Director Sacks Jonathan S was granted 46,512 shares and converted options into 8,696 shares (SEC Form 4)

Director Stonehill Capital Management Llc converted options into 8,696 shares and was granted 46,512 shares (SEC Form 4)

Director Silverman Lou was granted 46,512 shares, increasing direct ownership by 460% to 56,624 units (SEC Form 4)

Director Zierhoffer Carol J was granted 46,512 shares, increasing direct ownership by 55% to 130,892 units (SEC Form 4)

Director Asar Vinit K was granted 46,512 shares, increasing direct ownership by 460% to 56,624 units (SEC Form 4)

Director Felt Bruce C. Jr. was granted 46,512 shares, increasing direct ownership by 535% to 55,208 units (SEC Form 4)

Director Rodriguez Susan was granted 46,512 shares, increasing direct ownership by 110% to 88,618 units (SEC Form 4)

Director Stevens David B was granted 46,512 shares, increasing direct ownership by 62% to 121,002 units (SEC Form 4)